The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind
Open accessAbstract
PURPOSE: Retinitis pigmentosa (RP) is a group of inherited retinal degenerations leading to blindness due to photoreceptor loss. Retinitis pigmentosa is a rare disease, affecting only approximately 100 000 people in the United States. There is no cure and no approved medical therapy to slow or reverse RP. The purpose of this clinical trial was to evaluate the safety, reliability, and benefit of the Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc, Sylmar, CA) in restoring some visual function to subjects completely blind from RP. We report clinical trial results at 1 and 3 years after implantation. DESIGN: The study is a multicenter, single-arm, prospective clinical trial. PARTICIPANTS: There were 30 subjects in 10 centers in the United States and Europe. Subjects served as their own controls, that is, implanted eye versus fellow eye, and system on versus system off (native residual vision). METHODS: The Argus II System was implanted on and in a single eye (typically the worse-seeing eye) of blind subjects. Subjects wore glasses mounted with a small camera and a video processor that converted images into stimulation patterns sent to the electrode array on the retina. MAIN OUTCOME MEASURES: The primary outcome measures were safety (the number, seriousness, and relatedness of adverse events) and visual function, as measured by 3 computer-based, objective tests. RESULTS: A total of 29 of 30 subjects had functioning Argus II Systems implants 3 years after implantation. Eleven subjects experienced a total of 23 serious device- or surgery-related adverse events. All were treated with standard ophthalmic care. As a group, subjects performed significantly better with the system on than off on all visual function tests and functional vision assessments. CONCLUSIONS: The 3-year results of the Argus II trial support the long-term safety profile and benefit of the Argus II System for patients blind from RP. Earlier results from this trial were used to gain approval of the Argus II by the Food and Drug Administration and a CE mark in Europe. The Argus II System is the first and only retinal implant to have both approvals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subretinal electronic chips allow blind patients to read letters and combine them to words
Zrenner, E., Bartz-Schmidt, K. U., Benav, H., Besch, D., Bruckmann, A., Gabel, V.-P., Gekeler, F., Greppmaier, U., Harscher, A., Kibbel, S., et al. (2011) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2010.1747 · Cited by 819
Interim results from the international trial of Second Sight's visual prosthesis
Humayun, M. S., Dorn, J. D., da Cruz, L., Dagnelie, G., Sahel, J.-A., Stanga, P. E., Cideciyan, A. V., Duncan, J. L., Eliott, D., Filley, E., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.09.028 · Cited by 700
Self-citationVeraart, C., Raftopoulos, C., Mortimer, J. T., Delbeke, J., Pins, D., Michaux, G., Vanlierde, A., Parrini, S., & Wanet-Defalque, M.-C. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00977-9 · Cited by 405
Three-Year Follow-up of the Tube Versus Trabeculectomy Study
Gedde, S. J., Schiffman, J. C., Feuer, W. J., Herndon, L. W., Brandt, J. D., & Budenz, D. L. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.06.018 · Cited by 380
Ahuja, A. K., Dorn, J. D., Caspi, A., McMahon, M. J., Dagnelie, G., daCruz, L., Stanga, P., Humayun, M. S., Greenberg, R. J., & Argus II Study Group (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.179622 · Cited by 289
Self-citationThe Activity Inventory: An Adaptive Visual Function Questionnaire
MASSOF, R. W., AHMADIAN, L., GROVER, L. L., DEREMEIK, J. T., GOLDSTEIN, J. E., RAINEY, C., EPSTEIN, C., & BARNETT, G. D. (2007) · Optometry and Vision Science · doi:10.1097/opx.0b013e3181339efd · Cited by 198
Dorn, J. D., Ahuja, A. K., Caspi, A., da Cruz, L., Dagnelie, G., Sahel, J.-A., Greenberg, R. J., McMahon, M. J., & Argus II Study Group, F. T. (2013) · JAMA Ophthalmology · doi:10.1001/2013.jamaophthalmol.221 · Cited by 177
Self-citationToward the development of a cortically based visual neuroprosthesis
Normann, R. A., Greger, B. A., House, P., Romero, S. F., Pelayo, F., & Fernandez, E. (2009) · Journal of Neural Engineering · doi:10.1088/1741-2560/6/3/035001 · Cited by 143
Advances in gene therapy technologies to treat retinitis pigmentosa
Petrs‐Silva, H., & Linden, R. (2013) · Clinical ophthalmology · doi:10.2147/opth.s38041 · Cited by 94
Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy
Sahni, J., Angi, M., Irigoyen, C., Semeraro, F., Romano, M., & Parmeggiani, F. (2011) · Current Genomics · doi:10.2174/138920211795860062 · Cited by 81
Cited by
Dias, M. F., Joo, K., Kemp, J. A., Fialho, S. L., da Silva Cunha, A., Woo, S. J., & Kwon, Y. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.004 · Cited by 413
Five-year safety and performance results from the argus II retinal prosthesis system clinical trial.
da Cruz, L., Dorn, J. D., Humayun, M. S., Dagnelie, G., Handa, J., Barale, P.-O., Sahel, J.-A., Stanga, P. E., Hafezi, F., Safran, A. B., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.06.049 · Cited by 359
Self-citationThe Argus® II Retinal Prosthesis System
Luo, Y. H.-L., & da Cruz, L. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.09.003 · Cited by 351
Retinal stimulation strategies to restore vision: fundamentals and systems
Yue, L., Weiland, J. D., Roska, B., & Humayun, M. S. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.05.002 · Cited by 272
Self-citationInherited Retinal Degenerations: Current Landscape and Knowledge Gaps
Duncan, J. L., Pierce, E. A., Laster, A. M., Daiger, S. P., Birch, D. G., Ash, J. D., Iannaccone, A., Flannery, J. G., Sahel, J. A., Zack, D. J., et al. (2018) · Translational Vision Science & Technology · doi:10.1167/tvst.7.4.6 · Cited by 257
Self-citationStingl, K., Schippert, R., Bartz-Schmidt, K. U., Besch, D., Cottriall, C. L., Edwards, T. L., Gekeler, F., Greppmaier, U., Kiel, K., Koitschev, A., et al. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00445 · Cited by 198
Advances in retinal prosthesis systems
Bloch, E., Luo, Y., & da Cruz, L. (2019) · Therapeutic Advances in Ophthalmology · doi:10.1177/2515841418817501 · Cited by 201
Electronic retinal implants and artificial vision: journey and present
Mills, J. O., Jalil, A., & Stanga, P. E. (2017) · Eye · doi:10.1038/eye.2017.65 · Cited by 133
Self-citationChenais, N. A. L., Airaghi Leccardi, M. J. I., & Ghezzi, D. (2021) · Communications Materials · doi:10.1038/s43246-021-00133-2 · Cited by 110
Fujikado, T., Kamei, M., Sakaguchi, H., Kanda, H., Endo, T., Hirota, M., Morimoto, T., Nishida, K., Kishima, H., Terasawa, Y., et al. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.16-20367 · Cited by 101
Erickson-Davis, C., & Korzybska, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0229189 · Cited by 83
Bioengineering strategies for restoring vision
Cehajic-Kapetanovic, J., Singh, M. S., Zrenner, E., & MacLaren, R. E. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00836-4 · Cited by 79
Geruschat, D. R., Richards, T. P., Arditi, A., Cruz, L., Dagnelie, G., Dorn, J. D., Duncan, J. L., Ho, A. C., Olmos de koo, L. C., Sahel, J., et al. (2016) · Clinical and Experimental Optometry · doi:10.1111/cxo.12359 · Cited by 77
Self-citationThe suprachoroidal space: from potential space to a space with potential
Moisseiev, E., Loewenstein, A., & Yiu, G. (2016) · Clinical Ophthalmology · doi:10.2147/opth.s89784 · Cited by 76
Finn, A., Grewal, D., & Vajzovic, L. (2018) · Clinical ophthalmology · doi:10.2147/opth.s137525 · Cited by 71
Optimization of pillar electrodes in subretinal prosthesis for enhanced proximity to target neurons
Flores, T., Lei, X., Huang, T., Lorach, H., Dalal, R., Galambos, L., Kamins, T., Mathieson, K., & Palanker, D. (2018) · Journal of Neural Engineering · doi:10.1088/1741-2552/aaac39 · Cited by 57
“Recent clinical trials of all these systems show some restoration of visual perception, with highest visual acuity reported of 20/1260 [8], 20/550 [9], and 20/4000 [7] for epiretinal, subretinal, and suprachoroidal prostheses, respectively.”
BackgroundLuo, Y. H.-L., Zhong, J. J., Clemo, M., & da Cruz, L. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.07.021 · Cited by 47
Self-citationBionic eye review - An update.
Nowik, K., Langwińska-Wośko, E., Skopiński, P., Nowik, K. E., & Szaflik, J. P. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.05.041 · Cited by 49
Caspi, A., Roy, A., Wuyyuru, V., Rosendall, P. E., Harper, J. W., Katyal, K. D., Barry, M. P., Dagnelie, G., & Greenberg, R. J. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-22377 · Cited by 47
Self-citationOne-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study
Schaffrath, K., Schellhase, H., Walter, P., Augustin, A., Chizzolini, M., Kirchhof, B., Grisanti, S., Wiedemann, P., Szurman, P., Richard, G., et al. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.1476 · Cited by 44
Self-citationOptimization of return electrodes in neurostimulating arrays
Flores, T., Goetz, G., Lei, X., & Palanker, D. (2016) · Journal of Neural Engineering · doi:10.1088/1741-2560/13/3/036010 · Cited by 43
Paraskevoudi, N., & Pezaris, J. S. (2019) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2018.00073 · Cited by 39
A Fully Integrated RF-Powered Energy-Replenishing Current-Controlled Stimulator
Ha, S., Kim, C., Park, J., Cauwenberghs, G., & Mercier, P. P. (2019) · IEEE Transactions on Biomedical Circuits and Systems · doi:10.1109/tbcas.2018.2881800 · Cited by 35
Retinal Stimulator ASIC Architecture Based on a Joint Power and Data Optical Link
Lemaire, W., Benhouria, M., Koua, K., Besrour, M., Gauthier, L.-P., Martin-Hardy, G., Rossignol, T., Roy, S., & Fontaine, R. (2021) · IEEE Journal of Solid-State Circuits · doi:10.1109/jssc.2020.3045141 · Cited by 32
Karapanos, L., Abbott, C. J., Ayton, L. N., Kolic, M., McGuinness, M. B., Baglin, E. K., Titchener, S. A., Kvansakul, J., Johnson, D., Kentler, W. G., et al. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.10.7 · Cited by 30
The argus ii retinal prosthesis system
Bloch, E., & da Cruz, L. (2020) · Prosthesis · doi:10.5772/intechopen.84947 · Cited by 31
Spectral distribution of local field potential responses to electrical stimulation of the retina
Wong, Y. T., Halupka, K., Kameneva, T., Cloherty, S. L., Grayden, D. B., Burkitt, A. N., Meffin, H., & Shivdasani, M. N. (2016) · Journal of Neural Engineering · doi:10.1088/1741-2560/13/3/036003 · Cited by 16
Factors affecting two-point discrimination in argus II patients
Yücel, E. I., Sadeghi, R., Kartha, A., Montezuma, S. R., Dagnelie, G., Rokem, A., Boynton, G. M., Fine, I., & Beyeler, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.901337 · Cited by 13
Self-citationImprovement in reading performance through training with simulated thalamic visual prostheses
Rassia, K. E. K., & Pezaris, J. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-31435-0 · Cited by 13
Metadata
- Authors
- Ho, A. C., Humayun, M. S., Dorn, J. D., da Cruz, L., Dagnelie, G., Handa, J., Barale, P.-O., Sahel, J.-A., Stanga, P. E., Hafezi, F., Safran, A. B., Salzmann, J., Santos, A., Birch, D., Spencer, R., Cideciyan, A. V., de Juan, E., Duncan, J. L., Eliott, D., Fawzi, A., Olmos de Koo, L. C., Brown, G. C., Haller, J. A., Regillo, C. D., Del Priore, L. V., Arditi, A., Geruschat, D. R., & Greenberg, R. J.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 122
- Issue
- 8
- Pages
- 1547-1554
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W1912107527
- Cited by
- 260
- References
- 18
- FWCI
- 15.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.